Alopecia areata induced by Adalimumab in a patient with Crohn's disease

Dermatol Ther. 2022 Dec;35(12):e15940. doi: 10.1111/dth.15940. Epub 2022 Nov 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / adverse effects
  • Alopecia Areata* / chemically induced
  • Alopecia Areata* / diagnosis
  • Crohn Disease* / drug therapy
  • Humans
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha

Substances

  • Adalimumab
  • Tumor Necrosis Factor-alpha

Supplementary concepts

  • Diffuse alopecia